SPDR Series Trust SPDR S&P Biotech ETF (XBI): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
XBI Stock Price Chart Interactive Chart >
XBI Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $80.70 | 52-week high | $134.79 |
| Prev. close | $79.32 | 52-week low | $61.78 |
| Day low | $78.77 | Volume | 4,362,634 |
| Day high | $81.49 | Avg. volume | 13,490,731 |
| 50-day MA | $84.97 | Dividend yield | 0.00001% |
| 200-day MA | $85.58 |
SPDR Series Trust SPDR S&P Biotech ETF (XBI) ETF Bio
The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.
XBI ETF Info
| Issuer | State Street Global Advisors |
| Expense Ratio | 0.35% |
| Underlying Index | S&P Biotechnology Select Industry Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 7.42B |
| Net Asset Value (NAV) | $79.36 |
| Options? | Yes |
| Total Holdings | 156 |
XBI Top Holdings
| Symbol | Company | % of Total |
| BIIB | Biogen Inc. | 1.39% |
| ABBV | AbbVie Inc | 1.12% |
| BHVN | Biohaven Pharmaceutical Holding Company Ltd. | 1.12% |
| GBT | Global Blood Therapeutics Inc | 1.12% |
| CCXI | ChemoCentryx Inc | 1.11% |
| VRTX | Vertex Pharmaceuticals Inc | 1.11% |
| APLS | Apellis Pharmaceuticals Inc. | 1.08% |
| GILD | GILEAD SCI | 1.07% |
| NBIX | Neurocrine Biosciences Inc | 1.07% |
| CRSP | CRISPR Therapeutics AG | 1.07% |
XBI Price Returns
| 1-mo | -3.62% |
| 3-mo | -0.36% |
| 6-mo | -13.53% |
| 1-year | -36.04% |
| 3-year | 5.30% |
| 5-year | -8.08% |
| YTD | -27.92% |
| 2021 | -20.45% |
| 2020 | 48.33% |
| 2019 | 32.56% |
| 2018 | -15.28% |
| 2017 | 43.77% |
XBI Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||